Tissue-Based Diagnostic Biomarkers of Aggressive Variant Prostate Cancer: A Narrative Review

O Kouroukli, V Bravou, K Giannitsas, V Tzelepi - Cancers, 2024 - mdpi.com
Simple Summary Metastatic prostate cancer is traditionally treated with androgen
deprivation therapy. The introduction of second-generation antiandrogens into clinical …
相关文章
[HTML] nih.gov

[HTML][HTML] Tissue-Based Diagnostic Biomarkers of Aggressive Variant Prostate Cancer: A Narrative Review

O Kouroukli, V Bravou, K Giannitsas, V Tzelepi - Cancers, 2024 - ncbi.nlm.nih.gov
Prostate cancer (PC) is a common malignancy among elderly men, characterized by great
heterogeneity in its clinical course, ranging from an indolent to a highly aggressive disease …

Tissue-Based Diagnostic Biomarkers of Aggressive Variant Prostate Cancer: A Narrative Review

O Kouroukli, V Bravou, K Giannitsas, V Tzelepi - Cancers, 2024 - europepmc.org
Prostate cancer (PC) is a common malignancy among elderly men, characterized by great
heterogeneity in its clinical course, ranging from an indolent to a highly aggressive disease …

Tissue-Based Diagnostic Biomarkers of Aggressive Variant Prostate Cancer: A Narrative Review

O Kouroukli, V Bravou, K Giannitsas, V Tzelepi - Cancers, 2024 - pubmed.ncbi.nlm.nih.gov
Prostate cancer (PC) is a common malignancy among elderly men, characterized by great
heterogeneity in its clinical course, ranging from an indolent to a highly aggressive disease …

Tissue-Based Diagnostic Biomarkers of Aggressive Variant Prostate Cancer: A Narrative Review.

O Kouroukli, V Bravou, K Giannitsas, V Tzelepi - Cancers, 2024 - europepmc.org
Prostate cancer (PC) is a common malignancy among elderly men, characterized by great
heterogeneity in its clinical course, ranging from an indolent to a highly aggressive disease …